Cancer care is witnessing transformative advancements, driven by innovative technologies and strategic collaborations. In 2024, several significant initiatives have been launched to enhance precision treatment, improve training for medical professionals, and expand access to cutting-edge therapies.
Growth of the Global Radiation Therapy Market
The global radiation therapy market is experiencing substantial growth, driven by the increasing incidence of cancer, particularly in developing and underdeveloped regions. The market size was estimated at US$ 7.44 billion in 2024, grew to US$ 7.86 billion in 2025, and is projected to reach approximately US$ 12.93 billion by 2034. With a CAGR of 5.73% from 2025 to 2034, this expansion highlights the rising demand for advanced radiotherapy solutions and the integration of innovative treatment methods.
Get All the Details in Our Solution – Download Brochure @ https://www.towardshealthcare.com/download-brochure/5415
Apollo Cancer Centres’ Robotic Stereotactic Radiotherapy Program
In July 2024, Mr. Dinesh Madhavan, President of Group Oncology and International at Apollo Hospital Enterprises Ltd, highlighted the impact of emerging technologies in cancer care. He emphasized how innovation paves the way for highly individualized and effective treatments.
A major step in this direction is the collaboration between Accuracy and Apollo Cancer Centres to introduce the Robotic Stereotactic Radiotherapy Program. This initiative aims to bolster training facilities across the ASEAN region, equipping physicists, therapists, and oncologists with the expertise required to leverage the latest CyberKnife technologies. By enhancing precision and efficiency in radiotherapy, the program seeks to elevate treatment standards and patient outcomes.
Leo Cancer Care’s UPLIFT Initiative for Upright Radiotherapy
In October 2024, Leo Cancer Care unveiled UPLIFT, a multi-million-euro initiative dedicated to research and training in upright radiation therapy. This ambitious project is designed to integrate upright radiotherapy into mainstream radiation treatment, with a strong focus on making radiotherapy more sustainable, accessible, and patient-centric.
Upright radiotherapy has the potential to revolutionize cancer treatment by offering increased comfort and precision for patients, particularly those with mobility challenges. The UPLIFT initiative will support clinical advancements and provide training programs to ensure widespread adoption of this cutting-edge approach.
Novartis Acquires Mariana Oncology for Radioligand Therapeutics
In May 2024, Novartis announced the acquisition of Mariana Oncology, a preclinical-stage biotechnology company based in Watertown, Massachusetts. Mariana Oncology specializes in developing radioligand therapeutics (RLTs), which offer a targeted approach to treating cancers with significant unmet needs.
This acquisition underscores Novartis’ commitment to expanding its portfolio in precision oncology. Radioligand therapies work by delivering radioactive isotopes directly to cancer cells, minimizing damage to healthy tissues and improving treatment efficacy. The integration of Mariana Oncology’s expertise is expected to accelerate advancements in RLTs, providing new hope for patients with complex cancer conditions.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/radiation-therapy-market-sizing
Invest in Our Premium Strategic Solution @ https://www.towardshealthcare.com/price/5415
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
